APA (7th ed.) Citation

SF, I., HM, L., T, L., K, J., AF, C., K, H., . . . P, J. (2022). Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity. Clinical and experimental rheumatology, 40(1), 198. https://doi.org/10.55563/clinexprheumatol/ico144

Chicago Style (17th ed.) Citation

SF, Issa, Lindegaard HM, Lorenzen T, Junker K, Christensen AF, Hørslev-Petersen K, Holmskov U, Sorensen GL, and Junker P. "Erratum Corrige: Increased Serum Levels of Microfibrillar-associated Protein 4 (MFAP4) Are Not Associated with Clinical Synovitis in Rheumatoid Arthritis but May Reflect Underlying Cardiovascular Comorbidity." Clinical and Experimental Rheumatology 40, no. 1 (2022): 198. https://doi.org/10.55563/clinexprheumatol/ico144.

MLA (9th ed.) Citation

SF, Issa, et al. "Erratum Corrige: Increased Serum Levels of Microfibrillar-associated Protein 4 (MFAP4) Are Not Associated with Clinical Synovitis in Rheumatoid Arthritis but May Reflect Underlying Cardiovascular Comorbidity." Clinical and Experimental Rheumatology, vol. 40, no. 1, 2022, p. 198, https://doi.org/10.55563/clinexprheumatol/ico144.